Last updated on April 18, 2014 at 15:19 EDT

Shire plc: First Quarter 2012 Results Date Notification – April 26, 2012

April 12, 2012

DUBLIN, April 12, 2012 /PRNewswire/ –

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,
will announce first quarter 2012 earnings on Thursday April 26, 2012.

        Results press release will be
        issued at:                    12:00 BST / 07:00 EDT
        Investor conference call
        time:                         14:00 BST / 09:00 EDT

Live conference call for investors:

Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial
Officer will host the investor and analyst conference call at 14:00 BST/9:00 EDT.

The details of the conference call are as follows:

        UK dial in:    0800-077-8492 or 0844-335-0351
        US dial in:    1-866-8048688 or 1-718-3541175
        dial in:       +44-844-335-0351
        Global Access
        Numbers:       http://www.btconferencing.com/globalaccess/?bid=54_attended
        ID:            338 270
        Live Webcast:  http://www.shire.com/shireplc/en/investors


A replay of the presentation will be available for two weeks by phone and by webcast
for one year. Details can be found on our Investor Relations website


Notes to editors


Shire’s strategic goal is to become the leading specialty biopharmaceutical company
that focuses on meeting the needs of the specialist physician. Shire focuses its business
on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal
diseases and regenerative medicine as well as opportunities in other therapeutic areas to
the extent they arise through acquisitions. Shire’s in-licensing, merger and acquisition
efforts are focused on products in specialist markets with strong intellectual property
protection and global rights. Shire believes that a carefully selected and balanced
portfolio of products with strategically aligned and relatively small-scale sales forces
will deliver strong results.

For further information on Shire, please visit the Company’s website:


For further information please contact:

        Investor Relations Souheil Salah (ssalah@shire.com)   +44-1256-894-160
                           Erin K. Kelly (erikelly@shire.com)  +1-781-482-9541

SOURCE Shire plc

Source: PR Newswire